PapersPMID:30108163
Randomised placebo-controlled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome.
What moved
1 findingHow to read these marks →- Decreases stool frequency
moderate
“Glutamine also (i) reduced daily bowel movement frequency (p<0.0001), (ii) improved stool form on the Bristol Stool Scale (p<0.0001), and (iii) normalized intestinal hyperpermeability (where hyperpermeability is defined as an elevated urinary lactulose/mannitol ratio > 0.07) (p<0.0001).”
- Study
- RCT
- Participants
- 106
- Duration
- 8 weeks
- Dose studied
- glutamine powder 5 g orally three times daily for 8 weeks
- Population
- adults with post-infectious diarrhoea-predominant IBS (IBS-D) and intestinal hyperpermeability
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- adults with post-infectious diarrhoea-predominant IBS (IBS-D) and intestinal hyperpermeability
- Participants
- 115
- Comparator
- placebo
- Duration
- 56 days
- Endpoints measured
- 5
L-glutamine